Molecular pathogenesis and mechanisms of thyroid cancer
M Xing - Nature Reviews Cancer, 2013 - nature.com
Thyroid cancer is a common endocrine malignancy. There has been exciting progress in
understanding its molecular pathogenesis in recent years, as best exemplified by the …
understanding its molecular pathogenesis in recent years, as best exemplified by the …
Molecular genetics and diagnosis of thyroid cancer
YE Nikiforov, MN Nikiforova - Nature Reviews Endocrinology, 2011 - nature.com
Thyroid cancer is a common type of endocrine malignancy, and its incidence has been
steadily increasing in many regions of the world. Initiation and progression of thyroid cancer …
steadily increasing in many regions of the world. Initiation and progression of thyroid cancer …
Integrated genomic characterization of papillary thyroid carcinoma
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Here, we
describe the genomic landscape of 496 PTCs. We observed a low frequency of somatic …
describe the genomic landscape of 496 PTCs. We observed a low frequency of somatic …
Characterizing dedifferentiation of thyroid cancer by integrated analysis
Understanding of dedifferentiation, an indicator of poo prognosis for patients with thyroid
cancer, has been hampered by imprecise and incomplete characterization of its …
cancer, has been hampered by imprecise and incomplete characterization of its …
[PDF][PDF] Guidelines for the management of thyroid cancer.
P Perros, K Boelaert, S Colley, C Evans… - Clinical …, 2014 - rouxgroup.org.uk
Guidelines for the management of thyroid cancer Page 1 CLINICAL ENDOCRINOLOGY
VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF THE SOCIETY FOR …
VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF THE SOCIETY FOR …
BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications
M Xing - Endocrine reviews, 2007 - academic.oup.com
In recent years, the T1799A B-type Raf kinase (BRAF) mutation in thyroid cancer has
received enthusiastic investigation, and significant progress has been made toward …
received enthusiastic investigation, and significant progress has been made toward …
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
M Xing, WH Westra, RP Tufano, Y Cohen… - The Journal of …, 2005 - academic.oup.com
Context: Use of BRAF mutation in papillary thyroid cancer (PTC) has the potential to improve
risk stratification of this cancer. Objective: The objective of the study was to investigate the …
risk stratification of this cancer. Objective: The objective of the study was to investigate the …
[HTML][HTML] Papillary thyroid cancer: genetic alterations and molecular biomarker investigations
MI Abdullah, SM Junit, KL Ng… - … journal of medical …, 2019 - ncbi.nlm.nih.gov
Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of
the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is …
the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is …
MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility
Objective: MicroRNA (miRNA) expression is deregulated in many types of human cancers.
We sought to investigate the expression patterns of miRNA in all major types of thyroid …
We sought to investigate the expression patterns of miRNA in all major types of thyroid …
Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas
AJ Adeniran, Z Zhu, M Gandhi… - The American journal …, 2006 - journals.lww.com
Papillary carcinoma is the most common type of thyroid malignancy. It has been recently
shown that these tumors commonly have one of three genetic alterations: BRAF point …
shown that these tumors commonly have one of three genetic alterations: BRAF point …